[
    [
        {
            "time": "2018-10",
            "original_text": "2018年10月疫苗行业季报(2018Q3)：五联苗及四价流感获批签发 4价和9价HPV供不应求",
            "features": {
                "keywords": [
                    "疫苗",
                    "五联苗",
                    "四价流感",
                    "9价HPV",
                    "供不应求",
                    "获批签发"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "2018年10月疫苗行业季报(2018Q3)：五联苗及四价流感获批签发 4价和9价HPV供不应求",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-10",
            "original_text": "[买入评级]康泰生物(300601)：符合预期 疫苗终端销售恢复迅速",
            "features": {
                "keywords": [
                    "康泰生物",
                    "买入评级",
                    "疫苗",
                    "终端销售",
                    "恢复迅速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物技术"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]康泰生物(300601)：符合预期 疫苗终端销售恢复迅速",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        }
    ]
]